Fabrication, characterization and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fabrication, characterization and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-21
DOI
10.1038/srep46688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved Survival of HER2+Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
- (2016) Keith L. Knutson et al. CANCER RESEARCH
- Micellar formulation of indocyanine green for phototherapy of melanoma
- (2015) Vaibhav Mundra et al. JOURNAL OF CONTROLLED RELEASE
- Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization
- (2015) Rodolfo Mastropasqua et al. Journal of Ophthalmology
- Functional Nanomaterials for Phototherapies of Cancer
- (2014) Liang Cheng et al. CHEMICAL REVIEWS
- Thermosensitive Liposome Formulated Indocyanine Green for Near-Infrared Triggered Photodynamic Therapy: In Vivo Evaluation for Triple-Negative Breast Cancer
- (2014) Colby S. Shemesh et al. PHARMACEUTICAL RESEARCH
- Single-Step Assembly of DOX/ICG Loaded Lipid–Polymer Nanoparticles for Highly Effective Chemo-photothermal Combination Therapy
- (2013) Mingbin Zheng et al. ACS Nano
- Treating Breast Cancer in the 21st Century: Emerging Biological Therapies
- (2013) Gabriel Tinoco et al. Journal of Cancer
- Gold nanoparticle conjugated PLGA–PEG–SA–PEG–PLGA multiblock copolymer nanoparticles: synthesis, characterization, in vivo release of rifampicin
- (2013) Mani Gajendiran et al. Journal of Materials Chemistry B
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer
- (2011) Sebastian P. Haen et al. Clinical & Developmental Immunology
- The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery
- (2011) Boudewijn E. Schaafsma et al. JOURNAL OF SURGICAL ONCOLOGY
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
- (2009) Chuda Chittasupho et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
- (2008) C.Simone Fishburn JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanomedicine: Application of Nanobiotechnology in Medical Practice
- (2008) K.K. Jain MEDICAL PRINCIPLES AND PRACTICE
- Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
- (2008) K. E. Coldwell et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now